ORBIMED ADVISORS LLC Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in AMARIN CORP PLC\UK ($AMRN) and 10% Owner in AMBIT BIOSCIENCES CORP ($AMBI) and 10% Owner in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Anthera Pharmaceuticals Inc ($ANTH) and 10% Owner in COMPLETE GENOMICS INC ($GNOM) and 10% Owner in Pacira Pharmaceuticals, Inc. ($PCRX) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).
ORBIMED ADVISORS LLC in INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director, 10% Owner
Holdings: 1,485,324 shares
Current Value: $168,688,247
Latest Transaction: Aug 27 2014
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in INTERCEPT PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, AMBI, ANTH, GNOM, ICPT, MYG, PCRX, RLYP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 302.34 | 400 | 120,936 | 1,485,324 | 1.5 M to 1.5 M (-0.03 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 301.36 | 5,400 | 1,627,344 | 1,485,724 | 1.5 M to 1.5 M (-0.36 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 300.11 | 45,058 | 13,522,356 | 1,491,124 | 1.5 M to 1.5 M (-2.93 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 299.13 | 10,400 | 3,110,952 | 1,536,182 | 1.5 M to 1.5 M (-0.67 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 297.26 | 1,990 | 591,547 | 1,546,582 | 1.5 M to 1.5 M (-0.13 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 296.59 | 10,010 | 2,968,866 | 1,548,572 | 1.6 M to 1.5 M (-0.64 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 295.52 | 25,442 | 7,518,620 | 1,558,582 | 1.6 M to 1.6 M (-1.61 %) |
| Aug 27 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 294.67 | 12,558 | 3,700,466 | 1,584,024 | 1.6 M to 1.6 M (-0.79 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 308.13 | 350 | 107,844 | 1,596,582 | 1.6 M to 1.6 M (-0.02 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 307.06 | 14,640 | 4,495,314 | 1,596,932 | 1.6 M to 1.6 M (-0.91 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 306.23 | 525 | 160,772 | 1,611,572 | 1.6 M to 1.6 M (-0.03 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 305.14 | 1,732 | 528,501 | 1,612,097 | 1.6 M to 1.6 M (-0.11 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 303.77 | 1,193 | 362,394 | 1,613,829 | 1.6 M to 1.6 M (-0.07 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 302.55 | 1,100 | 332,806 | 1,615,022 | 1.6 M to 1.6 M (-0.07 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 301.42 | 1,710 | 515,426 | 1,616,122 | 1.6 M to 1.6 M (-0.11 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 300.21 | 3,985 | 1,196,329 | 1,617,832 | 1.6 M to 1.6 M (-0.25 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 298.61 | 100 | 29,861 | 1,621,817 | 1.6 M to 1.6 M (-0.01 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 297.76 | 9,985 | 2,973,134 | 1,621,917 | 1.6 M to 1.6 M (-0.61 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 296.86 | 6,192 | 1,838,139 | 1,631,902 | 1.6 M to 1.6 M (-0.38 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 296.21 | 7,062 | 2,091,814 | 1,638,094 | 1.6 M to 1.6 M (-0.43 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 294.96 | 3,254 | 959,800 | 1,645,156 | 1.6 M to 1.6 M (-0.20 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 293.85 | 4,468 | 1,312,908 | 1,648,410 | 1.7 M to 1.6 M (-0.27 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 292.70 | 3,704 | 1,084,165 | 1,652,878 | 1.7 M to 1.7 M (-0.22 %) |
| Aug 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 324 | 0 | 0 | |
| Aug 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 324 | 0 | 1,656,582 | 1.7 M to 1.7 M (+0.02 %) |
| May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 325 | 0 | 324 | |
| May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 1,330 | 0 | 0 | |
| May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 325 | 0 | 1,656,258 | 1.7 M to 1.7 M (+0.02 %) |
| May 09 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 1,330 | 0 | 1,655,933 | 1.7 M to 1.7 M (+0.08 %) |
| Apr 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 320.00 | 81,305 | 26,017,600 | 1,654,603 | 1.7 M to 1.7 M (-4.68 %) |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 324 | 0 | 649 | |
| Feb 11 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 324 | 0 | 1,735,908 | 1.7 M to 1.7 M (+0.02 %) |
| Nov 12 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 325 | 0 | 973 | |
| Nov 12 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 325 | 0 | 1,735,584 | 1.7 M to 1.7 M (+0.02 %) |
| Oct 23 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 62.50 | 40,088 | 2,505,500 | 1,735,259 | 1.8 M to 1.7 M (-2.26 %) |
| Oct 17 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 62.50 | 376,585 | 23,536,563 | 1,775,347 | 2.2 M to 1.8 M (-17.50 %) |
| Aug 13 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 325 | 0 | 1,298 | |
| Aug 13 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 325 | 0 | 2,151,932 | 2.2 M to 2.2 M (+0.02 %) |
| May 13 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 324 | 0 | 1,623 | |
| May 13 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 324 | 0 | 2,151,607 | 2.2 M to 2.2 M (+0.02 %) |
| Oct 16 2012 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 10,500,000 | 0 | 0 | |
| Oct 16 2012 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 15.00 | 333,334 | 5,000,010 | 2,150,634 | 1.8 M to 2.2 M (+18.34 %) |
| Oct 16 2012 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,817,300 | 0 | 1,817,300 | 0 to 1.8 M |
Page: 1